NCT07115511

Combined Recanalization Therapy for Acute Large Vessel Occlusion Stroke

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 64 (estimated)
• Sponsor: Tianjin Huanhu Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this clinical trial is to evaluate the efficacy and safety of combined recanalization therapy in patients who cannot be recanalized by acute large vessel occlusive stroke. The main questions it aims to answer are: 1、Proportion of subjects with mRs score of 0-1 at 90 days after surgery Participants will: 1、In acute large vessel occlusive stroke, if traditional means cannot be recanalized, combined recanalization surgery (including arteriotomy and thrombectomy, cerebrovascular bypass surgery) is performed.

Conditions

• Stroke

Interventions

Type	Name	Description
PROCEDURE	Surgery	Recombined recanalization surgery

Timeline

• Start date: 2024-12-01
• Primary completion: 2026-11-30
• Completion: 2026-11-30
• First posted: 2025-08-11
• Last updated: 2025-08-11

Locations

1 site across 1 country: China